The Use of Radiolabeled Antibodies for the Localisation of Tumours

  • A. R. Bradwell
Part of the Developments in Oncology book series (DION, volume 21)


Tumour diagnosis is becoming increasingly dependent on the use of serum and tissue markers. These are usually proteins produced in excess by malignant cells that may be used to identify malignant tissue. It was soon realised that antibodies against these proteins could specifically identify tumour tissue in histological sections and more recently, with attached radiolabels, could be used for in vivo tumour localisation (known as radioimmunodetection—RAID—or radioimmunolocalisation—RIL). The appeal of the technique is that tumours are localised on the basis of specific biochemical substances rather than on general characteristics such as density (CT scanning, etc.). RAID has been particularly applied to tumours of the gastrointestinal tract and other organs producing carcinoembryonic antigen, germ cell tissues producing alphafetoprotein or chorionic gonadotrophin, and a variety of rarer tumours. Although at present there is no definitive use for RAID, new developments suggest that its sensitivity will improve and its application will become important. This chapter describes the theory and development of the technique, clinical results to date, and future areas of development.


Carcinoembryonic Antigen Uptake Ratio Nuclear Medicine Technique Malignant Germ Cell Tumour Conventional Gamma Camera 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hericourt J, Richet C. Traitment d’un case de sarcome par la serotherapie. CR Acad Sci 120: 948–950, 1895.Google Scholar
  2. 2.
    Pressman D. The development and use of radiolabeled anti-tumour antibodies. Cancer Res 40: 2960–2964, 1980.PubMedGoogle Scholar
  3. 3.
    Bale WF, Spar IL, Goodland RL, Wolfe DE. In vivo and in vitro studies of labelled antibodies against rat kidney and Walker carcinoma. Proc Soc Biol Med 89: 564–568, 1955.Google Scholar
  4. 4.
    Quinones J, Mizejewski G, Bierwaltes WH. Choricocarcinoma scanning using radiolabeled antibody to chorionic gonadotrophs. J Nucl Med 12: 69–75, 1971.PubMedGoogle Scholar
  5. 5.
    Goldenberg DM, Preston DF, Primus FJ, Hansen HJ. Photoscan localisation of GW-39 tumours in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G. Cancer Res 34: 1–9, 1974.Google Scholar
  6. 6.
    Mach J-P, Carrel S, Merenda C, Sordat B, Cerottini J-C. In vivo localisation of radiolabeled antibodies to car-cinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248: 704–706, 1974.Google Scholar
  7. 7.
    Goldenberg DM, Deland F, Kim E, Bennett, S Primus FJ, Van Nagell JR Jr, Estes N, Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localisation of diverse cancers by external photoscanning. N Engl J Med 298: 1384–1388, 1978.PubMedCrossRefGoogle Scholar
  8. 8.
    Dykes PW, Hine KR, Bradwell AR, Blackburn JC, Reeder TA, Drolc Z, Booth SN. Localisation of tumour deposits by external scanning after injection of radiolabeled anti-carcinoembryonic antigen. Br Med J 280: 220–222, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Mach JP, Carrel S, Forni M, Ritschard J, Donath A, Alberto P. Tumour localisation of radiolabelled antibodies against carcinoembryonic antigen in patients with carcinoma, a critical evaluation. N Eng J Med 303: 5-10, 1980.CrossRefGoogle Scholar
  10. 10.
    Rockoff SD, Goodenough DJ, Mclntire KR. Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning. Cancer Res 40: 3054–3058, 1980.PubMedGoogle Scholar
  11. 11.
    Bradwell AR, Taylor JR, Dykes PW, Fairweather DS. Model for the radioimmunodetection of tumours. Prot Biol Fluids 31: 1983, in press.Google Scholar
  12. 12.
    Hedin A, Wahren B, Hammerstrom S. Tumour localisation of CEA-containing human tumours in nude mice by means of monoclonal anti-CEA antibodies. Int J Cancer 30: 547–552, 1982.PubMedCrossRefGoogle Scholar
  13. 13.
    Begent RHJ, Keep PA, Gren AJ, Searle F, Bagshawe KD, Jewkes RF, Jones BE, Barratt GM, Ryman BE. Liposomally entrapped second antibody improves tumour imaging with radiolabeled (first) anti tumour antibody. Lancet 2: 739–742, 1982.PubMedCrossRefGoogle Scholar
  14. 14.
    Fairweather DS, Irwin M, Bradwell AR, Dykes PW, Flinn RM. Computer analysis of antibody scans. Prot Biol Fluids 31: 1983, in press.Google Scholar
  15. 15.
    Stanworth QR, Turner MW. Immunochemical analysis of immunoglobulins and their subunits. In DM Weir (ed.), Handbook of experimental immunology. Oxford: Blackwell Scientific Publications, 1978, vol. 1, chapter 6.Google Scholar
  16. 16.
    Sternberger L. The unlabelled antibody peroxidase-antiperoxidase (PAP) method. In Immunocytochemistry, 2nd ed. New York: J Wiley and Sons, 1979, pp. 104–169.Google Scholar
  17. 17.
    Ey PL, Prowse SJ, Jenkin CR. Isolation of pure IgGl, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15: 429–436, 1978.PubMedCrossRefGoogle Scholar
  18. 18.
    European Pharmacopoeia. Tests for pyrogens 3: 58–60, 1971.Google Scholar
  19. 19.
    Watson-James SF, Fairweather DS, Bradwell AR. A shielded, sterile apparatus for iodinating proteins. Med Lab Sci 40: 67–68, 1981.Google Scholar
  20. 20.
    Epenetos AA, Britton KE, Mather S, Shepherd J, Granowska M, Taylor-Papadimitriou J, Nimmon CC, Durbin H, Hawkins LR, Malpas JS, Bodmer WF. Targetting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 2: 999–904, 1982.PubMedCrossRefGoogle Scholar
  21. 21.
    Bateman JE, Flesher AC, Fairweather DS, Bradwell AR. Positron tomography of the thyroid gland. Clin Sci Mol Med 65: 18p, 1983.Google Scholar
  22. 22.
    Sundberg MW, Mears CF, Goodwin DA, Diamanti CI. Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA. J Med Chem 17: 1304–1307, 1974.PubMedCrossRefGoogle Scholar
  23. 23.
    Krejcarek GE, Tucker KL. Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Commun 77: 581–585, 1977.PubMedCrossRefGoogle Scholar
  24. 24.
    Fairweather DS, Bradwell AR, Dykes PW, Vaughan AT, Watson-James SF, Chandler S. Improved tumour localisation using Ill-indium labelled antibodies. Br Med J 287: 167–170, 1983.CrossRefGoogle Scholar
  25. 25.
    Fairweather DS, Bradwell AR, Watson-James SF, Dykes PW, Chandler S, Hoffenberg R. Detection of thyroid tumours using radiolabeled anti-thyroglobulin. Clin Endocrinol 18: 563–570, 1983.CrossRefGoogle Scholar
  26. 26.
    Begent RHJ, Boultbee J, Jewkes R, Katz D, Mclvor J. Radioimmunolocalisation. Clin Oncol 2: 144–158, 1983.Google Scholar
  27. 27.
    Deland FH, Kim EE, Simmons G, Goldenberg DM. Imaging approach in radioimmunodetection. Cancer Res 40: 3046–3049, 1980.PubMedGoogle Scholar
  28. 29.
    Goldenberg DM, Kim EE, DeLand FH. Human Chorionic gonadotrophin radioantibodies in the radioim-munodetection of cancer and for disclosure of occult metastases. Proc Natl Acad Sci (USA) 78: 7754–7758, 1981.CrossRefGoogle Scholar
  29. 30.
    Mach JP, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso JD, Schreyer M, Girardet C, Accola RS, Carrel S. Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 2: 239–249, 1981.CrossRefGoogle Scholar
  30. 31.
    DeLand FH, Kim EE, Goldenberg DM. In vivo radioimmunodetection of cancer. In Wilson CG, Hardy JG, Frier M and Davis SS (eds.), Radionuclide imaging in drug research. London: Croom Helm, 1982, 181–202.Google Scholar
  31. 32.
    Berche C, Mach JP, Lumbroso, JD, Langlais C, Aubrey F, Buchegger F, Carrel S, Rougier P, Parmentier C, Tubiana M. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: First clinical results using radiolabeled monoclonal antibodies against carcinoembryonic antigen. Br Med J 285: 1447–1451, 1982.CrossRefGoogle Scholar
  32. 33.
    Smedley HM, Finan P., Lennox ES, Ritson A, Takei F, Wraight P, Sikora K. Localisation of metastatic carcinoma by radiolabeled monoclonal antibody. Br J Cancer 47: 253–259, 1983.PubMedCrossRefGoogle Scholar
  33. 34.
    Goldenberg DM, Kim EE, Bennett SJ, Nelson MO, DeLand FH. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms. Gastroenterology 84: 524–532, 1983.PubMedGoogle Scholar
  34. 35.
    Goldenberg DM, Kim EE, DeLand FH, Spremulli E, Nelson MO, Cockerman JP, Primus FJ, Corgan RL, Alpert E. Clinical studies on the radioimmunodetection of tumours containing alphafetoprotein. Cancer 45: 2500–2505, 1980.Google Scholar
  35. 36.
    Halsall AK, Fairweather DS, Bradwell AR, Blackburn JC, Dykes PW, Howell A, Reeder A, Hine KR. Localisation of malignant germ cell tumours by external scanning after injection of radiolabeled anti alphafetoprotein. Br Med J 283: 942–944, 1981.Google Scholar
  36. 37.
    Begent RHJ, Searle F, Stanway G, Jewkes RF, Jones BE, Vernon P, Bagshawe KD. Radioimmunolocalisa- tion of tumours by external scintigraphy after administration of 131I antibody to human chorionic gonadotrophin, J Soc Med 73: 624–630, 1980.Google Scholar
  37. 38.
    Goldenberg DM, Kim EE, DeLand FH, Van Nagell JR, Javadpour N. Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotrophin. Science 208: 1284–1286, 1980.Google Scholar
  38. 39.
    Fairweather DS, Bradwell AR, Dykes PW. Monoclonal antibodies for in vivo localisation. Lancet 2: 660, 1982.PubMedCrossRefGoogle Scholar
  39. 40.
    Ghose T, Norvell ST, Aquino J, Belitsky P, Tai J, Guclu A, Blair AH. Localisation of 1-131-labelled antibodies in human renal cell carcinomas and in a mouse hepatoma and correlation with tumour detection by photoscanning. Cancer Res 40: 3018–3031, 1980.PubMedGoogle Scholar
  40. 41.
    Farrands PA, Perkins AC, Pimm MV, Hardy JD, Embleton MJ, Baldwin RW, Hardcastle JD. Radioimmunodetection of human colorectal cancers by anti-tumour monoclonal antibody. Lancet 2: 397–400, 1982.PubMedCrossRefGoogle Scholar
  41. 42.
    Larson SM, Brown JP, Wright PW, Carrasquillo JA, Hellstrom I, Hellstrom KE. Imaging of melanoma with I-131-labelled monoclonal antibodies. J Nucl Med 24: 123–129, 1983.PubMedGoogle Scholar
  42. 43.
    Rainsbury RM, Ott RJ, Westwood JH, Kalirai TS, Coombes RC, McCready VR, Neville AM, Gazet J-C. Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with Indium-Ill. Lancet 2: 934–938, 1983.PubMedCrossRefGoogle Scholar
  43. 44.
    Dykes PW, Bradwell AR. Carcinoembryonic antigen radioimmunodetection. Gastroenterology 84: 651–653, 1983.PubMedGoogle Scholar
  44. 45.
    Lewis JCM, Bagshawe KD, Keep PA. The distribution of parenterally administered antibody to CEA in colorectal xenografts. Onco Develop Biol Med 3: 161–168, 1982.Google Scholar
  45. 46.
    Moshakis V, Bailey MJ, Ormerod MG, Westwood JH, Neville AM. Localisation of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen. Br J Cancer 43: 575–581, 1981.PubMedCrossRefGoogle Scholar
  46. 47.
    Fairweather DS, Bradwell AR, Dykes PW. Localisation of malignant germ cell tumours. Br Med J 284: 1478, 1982.CrossRefGoogle Scholar
  47. 48.
    Unanue ER, Karnovsky MJ. Ligand-induced movement of lymphocyte membrane macromolecules. V. Capping, cell movement and microtubular function in normal and lectin-treated lymphocytes. J Exp Med 140: 1207–1220, 1974.PubMedCrossRefGoogle Scholar
  48. 49.
    Hirai T, Yamamoto H, Hamoaka T. Relationship between carcinoembryonic antigen and major histocompatibility antigens in cultured human carcinoma cells. J Immunology 124: 2765–2771, 1980.Google Scholar
  49. 50.
    Stern P, Hagan P, Halpern S, Chen A, David G, Adams T, Desmond W, Brautigam K, Royston I. The effect of the radiolabel on the kinetics of monoclonal anti-CEA in a nude mouse-human colon tumour model. In Mitchel MS, Oettgen HF, (eds.), Hybridomas in cancer diagnosis and treatment. New York: Raven Press 1982, 245–253.Google Scholar
  50. 51.
    Searle F. Boden J, Lewis JCM, Bagshawe KD. A human choriocarcinoma xenograft in nude mice; a model for the study of antibody localisation. Br J Cancer 44: 137–144, 1981.PubMedCrossRefGoogle Scholar
  51. 52.
    Bradwell AR, Vaughan A, Fairweather DS, Dykes PW. Improved radio-immuno-detection of tumours using a second antibody. Lancet 1: 247, 1983.PubMedCrossRefGoogle Scholar
  52. 53.
    Bradwell AR, Fairweather DS, Keeling A, Watson-James S, Vaughan A, Dykes PW. Antibody interactions in the radioimmunodetection of tumours. Clin Sci Mol Med 65: 31p, 1983.Google Scholar
  53. 54.
    Glennie MJ, Stevenson GT. Univalent antibodies kill tumour cells in vitro and in vivo. Nature 295: 712–713, 1982.PubMedCrossRefGoogle Scholar
  54. 55.
    Brownell GL, Budinger TF, Lauterbur PL, Megeer PL. Positron tomography and nuclear magnetic resonance imaging. Science 215: 619–626, 1982.PubMedCrossRefGoogle Scholar
  55. 56.
    Bateman JE, Flescher AL, Fairweather DS, Bradwell AR, Wilkinson R. In vivo imaging of the human thyroid with the Rutherford positron camera using 124I. Science and Engineering Research Council Rutherford Laboratory Report RL: 8L - 36, 1982.Google Scholar
  56. 57.
    Brault JW, White OR. The analysis and restoration of astronomical data via the fast fourier transform. Astr Astrophys 13: 169–189, 1971.Google Scholar
  57. 58.
    Khaw BA, Fallon JT, Strauss HW, Harbe E. Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-lll-diethylene triamine pentaacetic acid. Science 209: 295–297, 1980.PubMedCrossRefGoogle Scholar
  58. 59.
    Skromne-Kadlubik G, Celis C, Ferez A. Cysticerosis of the nervous system: Diagnosis by means of specific radioimmunoscan. Ann Neurol 2: 343–344, 1977.CrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston/Dordrecht/Lancaster 1985

Authors and Affiliations

  • A. R. Bradwell

There are no affiliations available

Personalised recommendations